Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
Q1 2026 earnings • released • EPS beat +15,91% • Revenue beat +3,27%
See results
BAX:NYSE
Baxter International Inc
17,21 US$
-2,10%
(-0,37) 1D
17,22 US$
+0,06% (+0,010)
After hours
Closed: 1 may, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Açın
17,84 US$
High
17,85 US$
Low
17,04 US$
Mkt. cap
8,88 mlrd
Avg. vol.
8,35 mln
Volume
10,87 mln
Dividend
0,23%
Quarterly dividend
0,01 US$
Ex dividend date
28 noy 2025
52-wk high
32,68 US$
52-wk low
15,73 US$
EPS
-1,75 US$
Beta
0,62
Shares outstanding
516,25 mln
No. of employees
38K
News stories
From sources across the web
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37,5K
Founded1931
HeadquartersDeerfield, İllinoys, Amerika Birləşmiş Ştatları
SectorMedical device
Websitebaxter.com
Last report
30 apr 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0,36/ (0,31 est.)USD
+15,91%beat
Revenue / Estimate
2,70 mlrd/ (2,62 mlrd est.)USD
+3,27%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
2,62 mlrd
2,81 mlrd
2,84 mlrd
2,97 mlrd
Cost of goods sold
1,63 mlrd
1,67 mlrd
1,81 mlrd
2,01 mlrd
Cost of revenue
1,63 mlrd
1,67 mlrd
1,81 mlrd
2,01 mlrd
Research and development expenses
138,00 mln
134,00 mln
115,00 mln
116,00 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
648,00 mln
628,00 mln
669,00 mln
675,00 mln
Operating expense
732,00 mln
710,00 mln
734,00 mln
741,00 mln
Total operating expenses
2,36 mlrd
2,38 mlrd
2,55 mlrd
2,76 mlrd
Operating income
262,00 mln
434,00 mln
287,00 mln
219,00 mln
Other non operating income
2,00 mln
-1,00 mln
2,00 mln
3,00 mln
EBT including unusual items
-3,00 mln
133,00 mln
121,00 mln
-756,00 mln
EBT excluding unusual items
200,00 mln
363,00 mln
228,00 mln
161,00 mln
Income tax expense
-67,00 mln
11,00 mln
172,00 mln
279,00 mln
Effective tax rate
2.233,33%
8,27%
142,15%
-36,90%
Other operating expenses
-54,00 mln
-52,00 mln
-50,00 mln
-50,00 mln
Net income
126,00 mln
91,00 mln
-46,00 mln
-1,13 mlrd
Net profit margin
4,80%
3,24%
-1,62%
-37,93%
Earnings per share
0,55
0,59
0,69
0,44
Interest and investment income
17,00 mln
14,00 mln
10,00 mln
11,00 mln
Interest expense
-81,00 mln
-72,00 mln
-68,00 mln
-69,00 mln
Net interest expenses
-64,00 mln
-58,00 mln
-58,00 mln
-58,00 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
509,00 mln
691,00 mln
524,00 mln
459,00 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer